000 01519 a2200409 4500
005 20250516100845.0
264 0 _c20130912
008 201309s 0 0 eng d
022 _a1875-6638
024 7 _a10.2174/1573406411309030002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaczor, Agnieszka A
245 0 0 _aStructural and molecular docking studies of 4-benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with anticancer activity.
_h[electronic resource]
260 _bMedicinal chemistry (Shariqah (United Arab Emirates))
_cMay 2013
300 _a313-28 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aBinding Sites
650 0 4 _aCell Line
650 0 4 _aCell Line, Tumor
650 0 4 _aCrystallography, X-Ray
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsomerism
650 0 4 _aMolecular Docking Simulation
650 0 4 _aMolecular Structure
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPyrroles
_xchemistry
650 0 4 _aTriazoles
_xchemical synthesis
700 1 _aPitucha, Monika
700 1 _aKarczmarzyk, Zbigniew
700 1 _aWysocki, Waldemar
700 1 _aRzymowska, Jolanta
700 1 _aMatosiuk, Dariusz
773 0 _tMedicinal chemistry (Shariqah (United Arab Emirates))
_gvol. 9
_gno. 3
_gp. 313-28
856 4 0 _uhttps://doi.org/10.2174/1573406411309030002
_zAvailable from publisher's website
999 _c21902541
_d21902541